# Waymark

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/waymark

- Industry: Healthcare
- Headquarters: San Francisco, US
- Website: www.waymarkcare.com
- Total disclosed funding: $67M
- Latest round: Series A (Jun 30, 2023)
- Investors on record: 4

## About

Based in California, US, and founded in 2021, Waymark, Inc. operates as a Medicaid provider-enablement company intended to improve healthcare access and outcomes among Medicaid beneficiaries. The company was co-founded by Rajaie Batniji (CEO), and Sanjay Basu. In October 2023, Waymark, Inc. raised 42 million in equity and debt fundng led by returning investor Lux Capital, with participation from other returning investors Andreessen Horowitz, New Enterprise Associates, and new investor CVS Health Ventures.

The company's objective is to assist Medicaid patients with better healthcare by allowing technology-based community care solutions. The firm trains and deploys community-based teams, as well as a coordinator/social worker, to primary care providers, aiding them in reducing their workload and enhancing communication between practitioners, patients, and the community. Waymark, Inc. also collaborates with a network of health plans to provide Medicaid beneficiaries with exclusive benefits and furthermore offers medical assistance through pharmacists.

Waymark, Inc. will use the October 2023 funding to enhance its healthcare platform, hire and train new hires, and expand product offerings.

## Funding rounds

- Series A, Jun 30, 2023, $22M — New Enterprise Associates, Lux Capital, Andreessen Horowitz, CVS Health Ventures
- Series A, Jan 4, 2022, $45M — New Enterprise Associates, Lux Capital, Andreessen Horowitz

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Series A
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series A
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series A